These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 35182734)
1. Mechanisms of antidiabetic drugs and cholesterol efflux: A clinical perspective. Ahmadi A; Bagheri Ekta M; Sahebkar A Drug Discov Today; 2022 Jun; 27(6):1679-1688. PubMed ID: 35182734 [TBL] [Abstract][Full Text] [Related]
2. ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis. Ye D; Lammers B; Zhao Y; Meurs I; Van Berkel TJ; Van Eck M Curr Drug Targets; 2011 May; 12(5):647-60. PubMed ID: 21039336 [TBL] [Abstract][Full Text] [Related]
3. Caveolin-1 and ATP binding cassette transporter A1 and G1-mediated cholesterol efflux. Wang F; Gu HM; Zhang DW Cardiovasc Hematol Disord Drug Targets; 2014; 14(2):142-8. PubMed ID: 24801727 [TBL] [Abstract][Full Text] [Related]
4. Foam cells in atherosclerosis. Yu XH; Fu YC; Zhang DW; Yin K; Tang CK Clin Chim Acta; 2013 Sep; 424():245-52. PubMed ID: 23782937 [TBL] [Abstract][Full Text] [Related]
5. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells. Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381 [TBL] [Abstract][Full Text] [Related]
6. Insulin suppresses HDL-mediated cholesterol efflux from macrophages through inhibition of neutral cholesteryl ester hydrolase and ATP-binding cassette transporter G1 expressions. Yamashita M; Tamasawa N; Matsuki K; Tanabe J; Murakami H; Matsui J; Suda T J Atheroscler Thromb; 2010 Nov; 17(11):1183-9. PubMed ID: 20733269 [TBL] [Abstract][Full Text] [Related]
12. Astaxanthin enhances ATP-binding cassette transporter A1/G1 expressions and cholesterol efflux from macrophages. Iizuka M; Ayaori M; Uto-Kondo H; Yakushiji E; Takiguchi S; Nakaya K; Hisada T; Sasaki M; Komatsu T; Yogo M; Kishimoto Y; Kondo K; Ikewaki K J Nutr Sci Vitaminol (Tokyo); 2012; 58(2):96-104. PubMed ID: 22790567 [TBL] [Abstract][Full Text] [Related]
13. [Role of the ABC transporters A1 and G1, key reverse cholesterol transport proteins, in atherosclerosis]. Demina EP; Miroshnikova VV; Schwarzman AL Mol Biol (Mosk); 2016; 50(2):223-30. PubMed ID: 27239842 [TBL] [Abstract][Full Text] [Related]
14. Metformin ameliorates Ox-LDL-induced foam cell formation in raw264.7 cells by promoting ABCG-1 mediated cholesterol efflux. He X; Chen X; Wang L; Wang W; Liang Q; Yi L; Wang Y; Gao Q Life Sci; 2019 Jan; 216():67-74. PubMed ID: 30218721 [TBL] [Abstract][Full Text] [Related]
15. Reverse cholesterol transport and cholesterol efflux in atherosclerosis. Ohashi R; Mu H; Wang X; Yao Q; Chen C QJM; 2005 Dec; 98(12):845-56. PubMed ID: 16258026 [TBL] [Abstract][Full Text] [Related]
16. Identification of a novel partial agonist of liver X receptor α (LXRα) via screening. Li N; Wang X; Zhang J; Liu C; Li Y; Feng T; Xu Y; Si S Biochem Pharmacol; 2014 Dec; 92(3):438-47. PubMed ID: 25450668 [TBL] [Abstract][Full Text] [Related]
17. PRMT2 inhibits the formation of foam cell induced by ox-LDL in RAW 264.7 macrophage involving ABCA1 mediated cholesterol efflux. Li YY; Zhou SH; Chen SS; Zhong J; Wen GB Biochem Biophys Res Commun; 2020 Mar; 524(1):77-82. PubMed ID: 31980179 [TBL] [Abstract][Full Text] [Related]
18. Reduced expression of ATP-binding cassette transporter G1 increases cholesterol accumulation in macrophages of patients with type 2 diabetes mellitus. Mauldin JP; Nagelin MH; Wojcik AJ; Srinivasan S; Skaflen MD; Ayers CR; McNamara CA; Hedrick CC Circulation; 2008 May; 117(21):2785-92. PubMed ID: 18490524 [TBL] [Abstract][Full Text] [Related]
19. Regulation of cholesterol efflux from macrophages. Marcel YL; Ouimet M; Wang MD Curr Opin Lipidol; 2008 Oct; 19(5):455-61. PubMed ID: 18769226 [TBL] [Abstract][Full Text] [Related]
20. Brothers in Arms: ABCA1- and ABCG1-Mediated Cholesterol Efflux as Promising Targets in Cardiovascular Disease Treatment. Frambach SJCM; de Haas R; Smeitink JAM; Rongen GA; Russel FGM; Schirris TJJ Pharmacol Rev; 2020 Jan; 72(1):152-190. PubMed ID: 31831519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]